Association of vitamin B12 with pro-inflammatory cytokines and biochemical markers related to cardiometabolic risk in Saudi subjects

Nutrients

Volumn 8, Issue 9, 2016, Pages

  Al Daghri, Nasser M ^a   Rahman, Shakilur ^a   Sabico, Shaun ^a   Yakout, Sobhy ^a   Wani, Kaiser ^a   Al Attas, Omar S ^a   Saravanan, Ponnusamy ^b   Tripathi, Gyanendra ^a,b,c   McTernan, Philip G ^b   Alokail, Majed S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Cardiometabolic diseases; Resistin; TNF ; Vitamin B12

Indexed keywords

ADIPONECTIN; BIOCHEMICAL MARKER; CYANOCOBALAMIN; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HIP CIRCUMFERENCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; SAUDI ARABIA; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADIPONECTIN; ADOLESCENT; ADULT; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RESISTIN; RISK FACTORS; SAUDI ARABIA; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12; WAIST CIRCUMFERENCE;

EID: 84987722717     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8090460     Document Type: Article

References (35)

1. Mahalle, N., Kulkarni, M.V., Garg, M.K., Naik, S.S. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J. Cardiol. 2013, 61, 289–294. [CrossRef] [PubMed]
2. Oh, R., Brown, D.L. Vitamin B12 deficiency. Am. Fam. Physician 2003, 67, 979–986. [PubMed]
3. Guéant, J.-L., Alpers, D.H. Vitamin B12, a fascinating micronutrient, which influences human health in the very early and later stages of life. Biochimie 2013, 95, 967–969. [CrossRef] [PubMed]
4. Sadeghian, S., Fallahi, F., Salarifar, M., Davoodi, G., Mahmoodian, M., Fallah, N., Darvish, N., Karimi, S., Tehran Heart Center. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovas. Disord. 2006, 6, 38. [CrossRef] [PubMed]
5. Battaglia-Hsu, S.F., Akchiche, N., Noel, N., Alberto, J.M., Jeannesson, E., Orozco-Barrios, C.E., Martinez-Fong, D., Daval, J.L., Gueant, J.L. Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. Proc. Natl. Acad. Sci. USA 2009, 106, 21930–21935. [CrossRef] [PubMed]
6. Pawlak, R. Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegatarians? Am. J. Prev. Med. 2015, 48, e11–e26. [CrossRef] [PubMed]
7. Lai, W.K., Kan, M.Y. Homocysteine-induced endothelial dysfunction. Ann. Nutr. Metab. 2015, 67, 1–12. [CrossRef] [PubMed]
8. Fratoni, V., Brandi, M.L. B vitamins, homocysteine and bone health. Nutrients 2015, 7, 2176–2192. [CrossRef] [PubMed]
9. Smits, M.M., Woudstra, P., Utzschneider, K.M., Tong, J., Gerchman, F., Faulenbach, M., Carr, D.B., Aston-Mourney, K., Chait, A., Knopp, R.H., et al. Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis. Ann. Epidemiol. 2013, 23, 415–421. [CrossRef] [PubMed]
10. Piya, M.K., McTernan, P.G., Kumar, S. Adipokine inflammation and insulin resistance: The role of glucose, lipids and endotoxin. J. Endocrinol. 2013, 216, T1–T15. [CrossRef] [PubMed]
11. Ardawi, M.S., Rouzi, A.A., Qari, M.H., Dahlawi, F.M., Al-Raddadi, R.M. Influence of age, sex, folate and vitamin B12 status on plasma homocysteine in Saudis. Saudi Med. J. 2002, 23, 959–968. [PubMed]
12. Abdulle, A.M., Pathan, J.Y., Moussa, N., Gariballa, S. Association between homocysteine and endothelial dysfunction markers in stroke disease. Nutr. Neursci. 2010, 13, 2–6. [CrossRef] [PubMed]
13. Popa, C., Netea, M.G., van Riel, P.L., van der Meer, J.W., Stalenhoef, A.F. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 2007, 48, 751–762. [CrossRef] [PubMed]
14. Chen, X., Andresen, B.T., Hill, M., Zhang, J., Booth, F., Zhang, C. Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction. Curr. Hypertens Rev. 2008, 4, 245–255. [CrossRef] [PubMed]
15. Weiss, N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr. Drug Metab. 2005, 6, 27–36. [CrossRef] [PubMed]
16. Lawrence de Koning, A.B., Werstuck, G.H., Zhou, J., Austin, R.C.: Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin. Biochem. 2003, 36, 431–441. [CrossRef]
17. Buysschaer, M., Dramais, A.S., Wallemacq, P.E., Hermans, M.P. Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000, 23, 1816–1822. [CrossRef]
18. Al-Daghri, N.M. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population. Saudi Med. J. 2007, 28, 339–346. [PubMed]
19. Li, Y., Jiang, C., Xu, G., Wang, N., Zhu, Y., Tang, C., Wang, X. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes 2008, 57, 817–827. [CrossRef] [PubMed]
20. Hotamisligil, G.S. Mechanisms of TNF-alpha-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes 1999, 107, 119–125. [CrossRef] [PubMed]
21. Moller, D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 2000, 11, 212–217. [CrossRef]
22. Kaya, C., Cengiz, S.D., Satiroglu, H. Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS. Reprod. Biomed. Online 2009, 19, 721–726. [CrossRef] [PubMed]
23. Stewart, C.P., Christian, P., Schulze, K.J., Arguello, M., LeClerq, S.C., Khatry, S.K., West, K.P., Jr. Low maternal vitamin B-12 status is associated with offspring insulin resistance regardless of antenatal micronutrient supplementation in rural Nepal. J. Nutr. 2011, 141, 1912–1917. [CrossRef] [PubMed]
24. Gammon, C.S., von Hurst, P.R., Coad, J., Kruger, R., Stonehouse, W. Vegetarianism, vitamin B12 status, and insulin resistance in a group of predominantly overweight/obese South Asian women. Nutrition 2012, 28, 20–24. [CrossRef] [PubMed]
25. Jamaluddin, M.S., Weakley, S.M., Yao, Q., Chen, C. Resistin: Functional roles and therapeutic considerations for cardiovascular disease. Brit. J. Pharmacol. 2012, 165, 622–632. [CrossRef] [PubMed]
26. Sheng, C.H., Di, J., Jin, Y., Zhang, Y.C., Wu, M., Sun, Y., Zhang, G.Z. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008, 33, 135–143. [CrossRef] [PubMed]
27. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., Lazar, M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409, 307–312. [CrossRef] [PubMed]
28. Gerber, M., Boettner, A., Seidel, B., Lammert, A., Bar, J., Schuster, E., Thiery, J., Kiewss, W., Kratzsch, J. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab. 2005, 90, 4503–4509. [CrossRef] [PubMed]
29. Filková, M., Haluzík, M., Gay, S., Šenolt, L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin. Immunol. 2009, 133, 157–170. [CrossRef] [PubMed]
30. Wang, H., Chen, D.Y., Cao, J., He, Z.Y., Zhu, B.P., Long, M. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin. Med. Sci. J. 2009, 24, 161–166. [CrossRef]
31. Hotamisligil, G.S. The irresistible biology of resistin. J. Clin. Investig. 2003, 111, 173–174. [CrossRef] [PubMed]
32. McTernan, C.L., McTernan, P.G., Harte, A.L., Levick, P.L., Barnett, A.H., Kumar, S. Resistin, central obesity, and type 2 diabetes. Lancet 2002, 359, 46–47. [CrossRef]
33. Pang, S.S., Le, Y.Y. Role of resistin in inflammation and inflammation-related diseases. Cell. Mol. Immunol. 2006, 3, 29–34. [PubMed]
34. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., Tarkowski, A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005, 174, 5789–5795. [CrossRef] [PubMed]
35. Stejskal, D., Adamovska, S., Bartek, J., Jurakova, R., Proskova, J. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Pap. 2003, 147, 63–69. [CrossRef]